Related Experiment Video
Updated: Aug 24, 2026

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection
Published on: May 7, 2020
Leflunomide-induced aseptic meningitis
Jean-David Cohen1, Christian Jorgensen, Jacques Sany
1Immuno-rheumatology department, Hôpital Lapeyronie, 34295 Montpellier cedex 5, France. jd-cohen@chu-montpellier.fr
Abstract:
Drug-induced aseptic meningitis is uncommon and occurs primarily in patients with autoimmune disease. We report the first known case of leflunomide-induced aseptic meningitis, in a patient with rheumatoid arthritis.
Insights
Leflunomide can cause aseptic meningitis, a rare condition primarily seen in patients with autoimmune diseases. This is the first reported case of leflunomide-induced aseptic meningitis in a rheumatoid arthritis patient.
Area of Science:
- Rheumatology
- Neurology
- Pharmacology
Background:
- Aseptic meningitis is an uncommon condition.
- It predominantly affects individuals with autoimmune diseases.
- Drug-induced meningitis is a rare but serious adverse effect.
Observation:
- A patient with rheumatoid arthritis developed aseptic meningitis.
- The patient was undergoing treatment with leflunomide.
- Leflunomide is a disease-modifying antirheumatic drug (DMARD).
Findings:
- This case represents the first documented instance of leflunomide-induced aseptic meningitis.
- The patient's symptoms resolved after discontinuation of leflunomide.
- This suggests a potential causal link between leflunomide and aseptic meningitis.
Implications:
- Clinicians should consider leflunomide as a potential cause of aseptic meningitis in patients with rheumatoid arthritis.
- Early recognition and drug withdrawal are crucial for patient recovery.
- Further research may be warranted to elucidate the mechanism of leflunomide-induced aseptic meningitis.
Related Concept Videos
Encephalitis l: Introduction
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Viral Meningitis
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology